AKT1 and cholangiocarcinoma: The PI3K/AKT signaling is up-regulated in CCA and, recently, we demonstrated the anti-survival and pro-apoptotic effect of the AKT inhibitor (MK2206) on primary IHCCA cell cultures [5].